Joseph G. Dauner

Array ( [id] => 20144266 [patent_doc_number] => 12378597 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-08-05 [patent_title] => Probe, probe set, and method for identifying desired DNA sequence in solution [patent_app_type] => utility [patent_app_number] => 17/109493 [patent_app_country] => US [patent_app_date] => 2020-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 20 [patent_no_of_words] => 5610 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 364 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17109493 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20563079 [patent_doc_number] => 12565682 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-03-03 [patent_title] => Methods of treating cancer [patent_app_type] => utility [patent_app_number] => 17/780798 [patent_app_country] => US [patent_app_date] => 2020-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 6101 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 180 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17780798 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17416851 [patent_doc_number] => 20220051755 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2022-02-17 [patent_title] => Method to Use Gene Expression to Determine Likelihood of Clinical Outcome of Renal Cancer [patent_app_type] => utility [patent_app_number] => 16/952566 [patent_app_country] => US [patent_app_date] => 2020-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36154 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16952566 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17416851 [patent_doc_number] => 20220051755 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2022-02-17 [patent_title] => Method to Use Gene Expression to Determine Likelihood of Clinical Outcome of Renal Cancer [patent_app_type] => utility [patent_app_number] => 16/952566 [patent_app_country] => US [patent_app_date] => 2020-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36154 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16952566 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19226914 [patent_doc_number] => 12006548 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-06-11 [patent_title] => Treating or inhibiting severe sepsis based on measuring defensin alpha 4 (DEFA4) expression [patent_app_type] => utility [patent_app_number] => 16/951758 [patent_app_country] => US [patent_app_date] => 2020-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 166 [patent_figures_cnt] => 331 [patent_no_of_words] => 51032 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 170 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16951758 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16839913 [patent_doc_number] => 20210147925 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-20 [patent_title] => PARTITION-BASED DETERMINATION OF TARGET COPY NUMBER FOR SINGLE CELLS BY NON-ENDPOINT AMPLIFICATION [patent_app_type] => utility [patent_app_number] => 17/098006 [patent_app_country] => US [patent_app_date] => 2020-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9228 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17098006 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16832366 [patent_doc_number] => 11008607 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-05-18 [patent_title] => Spatially encoded biological assays [patent_app_type] => utility [patent_app_number] => 17/097824 [patent_app_country] => US [patent_app_date] => 2020-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 17913 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17097824 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16688793 [patent_doc_number] => 20210071269 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-11 [patent_title] => GENE SIGNATURES FOR CANCER PROGNOSIS [patent_app_type] => utility [patent_app_number] => 17/096755 [patent_app_country] => US [patent_app_date] => 2020-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57536 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17096755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18879580 [patent_doc_number] => 20240002949 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-04 [patent_title] => PANEL OF MIRNA BIOMARKERS FOR DIAGNOSIS OF OVARIAN CANCER, METHOD FOR IN VITRO DIAGNOSIS OF OVARIAN CANCER, USES OF PANEL OF MIRNA BIOMARKERS FOR IN VITRO DIAGNOSIS OF OVARIAN CANCER AND TEST FOR IN VITRO DIAGNOSIS OF OVARIAN CANCER [patent_app_type] => utility [patent_app_number] => 18/252634 [patent_app_country] => US [patent_app_date] => 2020-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9961 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18252634 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18862393 [patent_doc_number] => 20230416829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-28 [patent_title] => Immunotherapy Response Signature [patent_app_type] => utility [patent_app_number] => 18/036215 [patent_app_country] => US [patent_app_date] => 2020-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33925 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -39 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18036215 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16689648 [patent_doc_number] => 20210072125 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-11 [patent_title] => METHOD OF PARTIAL LYSIS AND ASSAY [patent_app_type] => utility [patent_app_number] => 17/091435 [patent_app_country] => US [patent_app_date] => 2020-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9098 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17091435 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16808354 [patent_doc_number] => 20210130907 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-06 [patent_title] => DETECTING OVARIAN CANCER [patent_app_type] => utility [patent_app_number] => 17/085542 [patent_app_country] => US [patent_app_date] => 2020-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47854 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17085542 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17990496 [patent_doc_number] => 20220356533 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-10 [patent_title] => BIOMARKER COMPOSITION FOR DIAGNOSING OR PREDICTING PROGNOSIS OF THYROID CANCER, COMPRISING PREPARATION CAPABLE OF DETECTING MUTATION IN PLEKHS1 GENE, AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/774424 [patent_app_country] => US [patent_app_date] => 2020-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13344 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17774424 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18531099 [patent_doc_number] => 20230236170 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-27 [patent_title] => REACTIVE AFFINITY PROBE-INTERACTION DISCOVERY PLATFORM [patent_app_type] => utility [patent_app_number] => 17/769173 [patent_app_country] => US [patent_app_date] => 2020-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6375 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -51 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17769173 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16778424 [patent_doc_number] => 20210115502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-22 [patent_title] => COMPOSITIONS AND METHODS FOR ANALYZING CELL-FREE DNA IN METHYLATION PARTITIONING ASSAYS [patent_app_type] => utility [patent_app_number] => 17/039642 [patent_app_country] => US [patent_app_date] => 2020-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40711 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17039642 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16728976 [patent_doc_number] => 20210096123 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-01 [patent_title] => NUCLEIC ACID METHYLATION ANALYSIS [patent_app_type] => utility [patent_app_number] => 17/037267 [patent_app_country] => US [patent_app_date] => 2020-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9252 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17037267 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16712318 [patent_doc_number] => 20210079465 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-18 [patent_title] => METHODS OF SEQUENCING NUCLEIC ACID MOLECULES [patent_app_type] => utility [patent_app_number] => 17/032023 [patent_app_country] => US [patent_app_date] => 2020-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43652 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17032023 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16571085 [patent_doc_number] => 20210010091 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-14 [patent_title] => CLASSIFIER FOR THE MOLECULAR CLASSIFICATION OF MULTIPLE MYELOMA [patent_app_type] => utility [patent_app_number] => 17/029564 [patent_app_country] => US [patent_app_date] => 2020-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6042 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 186 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17029564 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16712236 [patent_doc_number] => 20210079383 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-18 [patent_title] => METHODS AND SYSTEMS FOR T CELL RECEPTOR ANALYSIS [patent_app_type] => utility [patent_app_number] => 17/025822 [patent_app_country] => US [patent_app_date] => 2020-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48498 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -39 [patent_words_short_claim] => 155 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17025822 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16688781 [patent_doc_number] => 20210071257 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-11 [patent_title] => COMPOSITIONS AND METHODS FOR MAINTAINING SPLICING FIDELITY [patent_app_type] => utility [patent_app_number] => 17/023442 [patent_app_country] => US [patent_app_date] => 2020-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33517 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17023442 [rel_patent_id] =>[rel_patent_doc_number] =>)